Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Road-mapping versus ultrasound guidance for retrograde arterial puncture during angioplasty

Official title: Road Mapping Guided Puncture Versus Ultrasound Guided Puncture During Retrograde Angioplasty Feasibility and Safety

Run by Sohag University · NCT07427108 · Data updated 2026-11-12

This trial will test whether using road mapping or ultrasound to guide retrograde arterial puncture works better and is safer for adults with critical limb-threatening ischemia who need retrograde access during angioplasty.

More Peripheral Arterial Disease trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment32 (estimated)
SponsorSohag University
Academic / other
Locations1 site (Sohag)
StatusRecruiting
StartedFebruary 1, 2026
Main results expectedDecember 31, 2026
Study endsMarch 1, 2027
Registry record updatedFebruary 23, 2026
Trial IDNCT07427108 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with critical limb-threatening ischemia (Rutherford Class 5) who have failed or cannot achieve antegrade access and are planned for retrograde endovascular intervention, without local infection or prohibitive arterial calcification/anatomical distortion, are ideal candidates.

Probably not a fit

Patients with active infection at the puncture site, severe arterial calcification or anatomy that prevents safe retrograde puncture, or those who do not require retrograde access are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with critical limb-threatening ischemia who cannot obtain antegrade access and are scheduled for retrograde endovascular intervention will undergo retrograde arterial puncture guided either by road mapping (fluoroscopic roadmap) or by ultrasound. The study will compare technical measures such as puncture success rate and procedure-related access complications (for example hematoma, vessel dissection, or perforation). Procedures are performed at a single center and safety and feasibility outcomes will be recorded for each approach. The goal is to determine which guidance method provides more reliable access with fewer complications in this high-risk patient group.

Why it matters

Potential benefit: If successful, the preferred guidance method could increase the chance of successful retrograde access and reduce access-related complications, potentially improving limb salvage and procedural safety.

How similar studies have gone: Ultrasound guidance and fluoroscopic road mapping are both used in practice and have shown utility, but direct head-to-head comparisons specifically for retrograde puncture in CLTI are limited, so this feasibility/safety comparison is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria: -.

1. Adults : Both male and female participants.
2. Diagnosed with critical limp threatening ischemia (CLTI):

   significant occlusions in the femoropopliteal

   o Rutherford Class 5: Non-healing wounds or ulcers
3. Failed or unable to achieve antegrade access:

   Patients requiring retrograde puncture for the procedure.
4. Planned intervention with retrograde access: Candidates for endovascular interventions, including angioplasty, stent deployment

Exclusion criteria:

• Active infection at the puncture site: Any localized infection, particularly over the ankle region , will be an exclusion.

• Severe calcification or anatomical abnormalities: Patients with excessive arterial calcification or significant anatomical distortion preventing safe retrograde puncture.

Where it's running

  • Sohag University Hospital
    Sohag, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.